| Q48189559 | Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study |
| Q38935503 | Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats |
| Q37179677 | Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. |
| Q95642566 | Genus Boswellia as a new candidate for neurodegenerative disorders |
| Q36974939 | Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease. |
| Q41978118 | Molecular basis for the reduced catalytic activity of the naturally occurring T560M mutant of human 12/15-lipoxygenase that has been implicated in coronary artery disease. |
| Q35072707 | Neuroinflammation and memory: the role of prostaglandins |
| Q48562910 | Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice. |
| Q36465011 | Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. |
| Q42919329 | Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats |
| Q35287240 | Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone |
| Q38671719 | The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease. |
| Q37357296 | Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties |